Literature DB >> 20003161

Childhood immunization and atopic disease into middle-age--a prospective cohort study.

Melanie C Matheson1, E Haydn Walters, John A Burgess, Mark A Jenkins, Graham G Giles, John L Hopper, Michael J Abramson, Shyamali C Dharmage.   

Abstract

The association between childhood immunizations and risk of atopic diseases is unclear. No study has examined possible associations between childhood immunizations and such diseases in middle age. The Tasmanian Longitudinal Health Study (TAHS) is a population based cohort study of respiratory disease. The TAHS participants were followed from 7 to 44 yrs of age. Immunizations during childhood were examined for any association with asthma and atopic disease at age 44 yrs. Multivariable regression models were used to estimate relative risks while adjusting for confounders. Cox regression was used to estimate the association between childhood immunizations and asthma developing after the age of 7 yrs. We found no association between any childhood immunization (Diphtheria, Tetanus, Pertussis, Polio, Smallpox) and asthma (ORs ranged from 0.87 to 1.17 p > 0.05), eczema (ORs ranged from 0.99 to 1.07 p > 0.05), food allergy (ORs ranged from 0.97 to 1.11 p > 0.05), or hay fever (ORs ranged from 1.02 to 1.05 p > 0.05) at age 44. Nor did we find any association between childhood immunizations and an increased risk of incident asthma after the age of 7 yrs (Diphtheria HR = 1.06, 95% CI 0.82, 1.36; Tetanus HR = 1.13, 95% CI 0.88, 1.44; Pertussis HR = 1.03, 95% CI 0.81, 1.30; Polio HR = 1.15, 95% CI 0.86, 1.54; Smallpox HR = 1.21, 95% CI 0.99, 1.48; DTP HR = 1.05, 95% CI 0.85, 1.30). Our analysis does not support any association between common childhood immunizations and risk of asthma and atopic disease in middle-age. Our findings should provide reassurance that in terms of life time risk of asthma and atopic disease, childhood immunization is safe.

Entities:  

Mesh:

Year:  2009        PMID: 20003161     DOI: 10.1111/j.1399-3038.2009.00950.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  Tetanus vaccination is associated with differential DNA-methylation: Reduces the risk of asthma in adolescence.

Authors:  Vimala Devi Janjanam; Nandini Mukherjee; Gabrielle A Lockett; Faisal I Rezwan; Ramesh Kurukulaaratchy; Frances Mitchell; Hongmei Zhang; Hasan Arshad; John W Holloway; Wilfried Karmaus
Journal:  Vaccine       Date:  2016-11-17       Impact factor: 3.641

2.  Rising prevalence of asthma is sex-specific in a US farming population.

Authors:  Caroline A Motika; Charalampos Papachristou; Mark Abney; Lucille A Lester; Carole Ober
Journal:  J Allergy Clin Immunol       Date:  2011-08-15       Impact factor: 10.793

Review 3.  Food allergy: temporal trends and determinants.

Authors:  Moshe Ben-Shoshan; Elizabeth Turnbull; Ann Clarke
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.919

Review 4.  Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children.

Authors:  Gladymar Perez Chacon; Jessica Ramsay; Christopher G Brennan-Jones; Marie J Estcourt; Peter Richmond; Patrick Holt; Tom Snelling
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

5.  Vaccination and Allergic Sensitization in Early Childhood - The ALADDIN Birth Cohort.

Authors:  Jackie Swartz; Bernice Aronsson; Frank Lindblad; Hans Järnbert-Pettersson; Annika Scheynius; Göran Pershagen; Johan Alm
Journal:  EClinicalMedicine       Date:  2018-11-06

6.  A multidisciplinary effort to increase COVID-19 vaccination among the older adults.

Authors:  Aminath S Moosa; Yi M S Wee; Meng H Jaw; Qifan F Tan; Wan L D Tse; Chui Y Loke; Guan L A Ee; Chee C D Ng; Wai K Aau; Yi L E Koh; Ngiap C Tan
Journal:  Front Public Health       Date:  2022-08-01

Review 7.  Primary Prevention of Food Allergy-Environmental Protection beyond Diet.

Authors:  Hanna Sikorska-Szaflik; Barbara Sozańska
Journal:  Nutrients       Date:  2021-06-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.